Actelion (now Janssen Pulmonary Hypertension) logo

Actelion (now Janssen Pulmonary Hypertension) Employee Directory

Pharmaceutical ManufacturingBasel-Stadt, Switzerland201-500 Employees

Actelion, now known as Janssen Pulmonary Hypertension, operates in the pharmaceutical manufacturing industry and is based in Basel, Basel-Stadt, Switzerland. It is part of Janssen, a Johnson & Johnson company, with updates provided on Janssen's LinkedIn channel. The organization employs 201 to 500 people and maintains a web presence at https://janssen.com. The name Janssen Pulmonary Hypertension indicates its integration into Janssen's portfolio related to pulmonary hypertension. Publicly reported recent news shows Janssen Pharmaceuticals, Inc. engaging in external research collaborations with multiple partners, illustrating the kind of activity associated with the Janssen organization.

Find Actelion (now Janssen Pulmonary Hypertension) employees' phone numbers or email addresses

Actelion (now Janssen Pulmonary Hypertension) Global Highlights

Location
Employees

Europe
449

Minus sign iconPlus sign icon
  • Switzerland
    290
  • France
    53
  • United Kingdom Of Great Britain And Northern Ireland
    27
  • Italy
    24
  • Germany
    10
  • Greece
    9
  • Portugal
    5
  • Belgium
    5
  • Spain
    5
  • Sweden
    5
  • Netherlands
    5
  • Poland
    4
  • Austria
    3
  • Hungary
    2
  • Ireland
    1
  • Romania
    1

North America
263

Minus sign iconPlus sign icon
  • United States Of America
    235
  • Mexico
    14
  • Canada
    13
  • Panama
    1

Asia
76

Minus sign iconPlus sign icon
  • Japan
    18
  • Turkey
    17
  • China
    13
  • India
    8
  • Israel
    7
  • Russian Federation
    6
  • Singapore
    4
  • Malaysia
    1
  • Indonesia
    1
  • Philippines
    1

South America
10

Minus sign iconPlus sign icon
  • Brazil
    10

Oceania
6

Minus sign iconPlus sign icon
  • Australia
    6

Africa
3

Minus sign iconPlus sign icon
  • South Africa
    1
  • Tunisia
    1
  • Egypt
    1

Actelion (now Janssen Pulmonary Hypertension)'s Leadership

  • Vice President Head Of Business & Science Affairs at Actelion (now Janssen Pulmonary Hypertension)
    M. H. W.
    Vice President Head Of Business & Science Affairs
  • President at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    President
  • Head Of Clinical Science Early Projects at Actelion (now Janssen Pulmonary Hypertension)
    S. R.
    Head Of Clinical Science Early Projects
  • Head Of Clinical Development at Actelion (now Janssen Pulmonary Hypertension)
    J. H. P.
    Head Of Clinical Development
  • Head Of Enterprise Risk And Business Continuity Management at Actelion (now Janssen Pulmonary Hypertension)
    J. A.
    Head Of Enterprise Risk And Business Continuity Management
  • Owner at Actelion (now Janssen Pulmonary Hypertension)
    S. A.
    Owner
  • Senior Director, Clinical Science Pediatrics Program Head at Actelion (now Janssen Pulmonary Hypertension)
    C. L.
    Senior Director, Clinical Science Pediatrics Program Head
  • Vice-President, Head Clinical Pharmacology at Actelion (now Janssen Pulmonary Hypertension)
    J. D.
    Vice-President, Head Clinical Pharmacology

Actelion (now Janssen Pulmonary Hypertension) Employee Metrics

100%
50%
0%
2026
2025
  • Customer Success
  • Research
  • Program & Project Management
  • Operations
  • Sales
  • Other
  • Engineering
  • Administrative
  • Biotechnology
  • Healthcare Services
  • Legal

Contact profiles from Actelion (now Janssen Pulmonary Hypertension)

Name
Title
Contact
Location
Last Update
  • Lab Head at Actelion (now Janssen Pulmonary Hypertension)
    S. D.
    Lab Head
    China, Shanghai
    Mar 05, 2024
  • Corporate Officer Head Of Strategic Marketing Divison at Actelion (now Janssen Pulmonary Hypertension)
    T. M.
    Corporate Officer Head Of Strategic Marketing Divison
    Japan, Tokyo
    Apr 28, 2023
  • Senoir Head Of Research at Actelion (now Janssen Pulmonary Hypertension)
    H. S.
    Senoir Head Of Research
    Switzerland
    Oct 22, 2026
  • Scientific Director, Cmc Leader at Actelion (now Janssen Pulmonary Hypertension)
    J. S.
    Scientific Director, Cmc Leader
    Switzerland
    Jun 28, 2026
  • Director De Asuntos Regulatorios Y Calidad at Actelion (now Janssen Pulmonary Hypertension)
    S. C.
    Director De Asuntos Regulatorios Y Calidad
    Mexico, Mexico City
    Jun 27, 2026
  • Director Patients And Investigators Experience at Actelion (now Janssen Pulmonary Hypertension)
    Y. S.
    Director Patients And Investigators Experience
    Apr 14, 2026
  • Associate Global Brand Director at Actelion (now Janssen Pulmonary Hypertension)
    T. R.
    Associate Global Brand Director
    Switzerland, Basel-Landschaft
    Apr 13, 2026
  • Medical & Business Development Director at Actelion (now Janssen Pulmonary Hypertension)
    H. F.
    Medical & Business Development Director
    Poland, Mazovia
    Oct 17, 2026
  • Director at Actelion (now Janssen Pulmonary Hypertension)
    S. T.
    Director
    Switzerland, Basel-Landschaft
    Sep 14, 2026
  • Director Clinical Development Auditing And Postmarketing Qa at Actelion (now Janssen Pulmonary Hypertension)
    Y. L.
    Director Clinical Development Auditing And Postmarketing Qa
    Switzerland
    Jun 23, 2026

Frequently Asked Questions

What is Actelion (now Janssen Pulmonary Hypertension) known for?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) operates in the Pharmaceutical Manufacturing industry. You can contact Actelion (now Janssen Pulmonary Hypertension)'s main corporate office by phone at . Explore Actelion (now Janssen Pulmonary Hypertension)'s company overview page for more information.

What is Actelion (now Janssen Pulmonary Hypertension)'s most common email format?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) employees' email format typically follows the pattern of First.Last@actelion.com. Trying to find reliable and up-to-date employee contact data? Find more Actelion (now Janssen Pulmonary Hypertension) email formats with LeadIQ.

How many employees does Actelion (now Janssen Pulmonary Hypertension) have currently?

Minus sign iconPlus sign icon
Actelion (now Janssen Pulmonary Hypertension) has approximately 456 employees as of October 2026. These team members are located across 6 continents, including Europe, North America and Asia.

Who are Actelion (now Janssen Pulmonary Hypertension)'s key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Actelion (now Janssen Pulmonary Hypertension)'s key employees include:

  • Vice President Head Of Business & Science Affairs: M. H. W.
  • President: S. T.
  • Head Of Clinical Science Early Projects: S. R.
  • Head Of Clinical Development: J. H. P.
  • Head Of Enterprise Risk And Business Continuity Management: J. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.